| Page properties |
|---|
| Status | In progress |
|---|
| Version | 0.5 |
|---|
|
Descriptions:
| Term | description type | Language/acceptability | LangaugeLanguage/acceptability | Case significance |
|---|
Anaphylaxis caused by [agent] (disorder) | FSN | us:P | gb:P | ci |
Anaphylaxis caused by [agent] | SYN | us:P | gb:P | ci |
Concept model:
| Attribute Cardinality | Attribute | Value | role group number | Role group cardinality |
|---|
| 1..1 |
| Scg expression |
|---|
116680003|Is a (attribute)| |
|
| Scg expression |
|---|
39579001 |Anaphylaxis (disorder)| |
| 0 | N/A |
| 1..1 |
| Scg expression |
|---|
263502005 |Clinical course (attribute)| |
|
| Scg expression |
|---|
385315009 |Sudden onset (qualifier value)| |
| 0 | N/A |
| 1..1 |
| Scg expression |
|---|
308489006 |Pathological process (qualifier value)| |
| | 769260004 | Immunoglobulin E-mediated allergicAllergic process (qualifier value)| |
|
1 |
| 1..1 | 1..1 |
| Scg expression |
|---|
246075003|Causative agent (attribute)| |
|
| Scg expression |
|---|
[agent] << 105590001|Substance (substance)| OR << 373873005|Pharmaceutical / biologic product (product)| |
|
Definition status:
| Scg expression |
|---|
900000000000073002|Defined (core metadata concept)| |
Template Language
281647001 39579001 |Adverse reaction Anaphylaxis (disorder)|: [[~1..1]] { [[~0~1..1]] 363698007 370135005 |Finding site Pathological process (attribute)|= [[+id(< 123037004 |Body structure (body structure472964009 |Allergic process (qualifier value)|) @site ]], [[~1..1]] 246075003 |Causative agent (attribute)| = [[+id( << 105590001 |Substance (substance)| OR << 373873005 |Pharmaceutical / biologic product (product)| OR << 260787004 |Physical object (physical object)| OR << 78621006 |Physical force (physical force)|) @agent]] }
Applies to:
| Scg expression |
|---|
<< 417516000 |Anaphylaxis caused by substance (disorder)| |
Editorial guidelines for selection of Causative agent attribute value:
The following editorial guidelines apply to concepts in the International Release; editorial guidelines for concepts in national extensions may vary.
| Concept type | Allowed | Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.) |
|---|
| Substance base | yes | Concepts representing a substance base should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example: - 241939002 |Insulin-induced anaphylaxis (disorder)|
Expected classification: - Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy.
|
| Substance modification | no, unless documented as exception | Exceptions: None identified |
| Multiple substance | no, unless documented as exception | Exceptions: None identified |
| Disposition grouper | no, unless documented as exception | Exceptions: None identified |
| Role grouper | no, unless documented as exception | Exceptions: None identified |
| Structure grouper | no, unless documented as exception | Exceptions: None identified |
| Descendant of 373873005 |Pharmaceutical / biologic product (product)| | no, unless documented as exception | Exceptions: None identified |
Rules for description generation:
- For the FSN, align terming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag.
- For the PT, align terming and case sensitivity with the US and GB PT for the concept that is selected as the attribute value.
- In cases where neither the US or GB PT matches the FSN, excluding the semantic tag, a synonym corresponding to the FSN is required unless explicitly identified as an exception.Additional synonyms "[agent] adverse reaction" should be added. Other synonyms are not allowed unless explicitly identified as an exception.
JIRA ticket for implementation: